Dailypharm Live Search Close

Concerns about the introduction of the Reference Price

By Kim, Jung-Ju | translator Choi HeeYoung

21.10.28 06:00:45

°¡³ª´Ù¶ó 0
The MOHW responds to a written inquiry of the parliamentary audit to the National Assembly

Review of drug management considering individual drugs


The government expressed concern over the National Assembly's proposal to review the introduction of the Reference Pricing System. Although they sympathize with the need for rational drug price management, side effects such as an increase in the patient's economic burden are predicted from the reference price system itself.

Regarding price policies, such as proposals for mandatory general administration, it said that the pros and cons of the pharmaceutical industry and conflicts will be reviewed through collecting various opinions because social consensus is important.

The MOHW recently submitted a written response to such issues related to drug price policies proposed and inquired by the

Kim, Jung-Ju(jj0831@dailypharm.com)
If you want to see the full article, please JOIN US (click)